Rf. Schafers et al., Haemodynamic characterization of young normotensive men carrying the 825T-allele of the G-protein beta 3 subunit, PHARMACOGEN, 11(6), 2001, pp. 461-470
A C825T polymorphism was recently identified in the gene for the G-protein
beta3 subunit, the T-allele being associated with hypertension. To better u
nderstand the underlying pathophysiological mechanisms, we compared the hae
modynamics of young healthy males with and without the T-allele. In three s
tudies, subjects were investigated with regard to cardiac and vascular func
tion at rest and following intravenous administration of the beta -adrenoce
ptor antagonist, propranolol, and the alpha (2)-adrenoceptor agonist, alpha
-methylnoradrenaline, and with regard to local venous vasoconstriction in
the dorsal hand vein in situ following infusion of the alpha (2)-adrenocept
or agonist, azepexol. alpha (2)-Adrenoceptor agonists were chosen as vasoco
nstrictor drugs since alpha (2)-adrenoceptors couple to pertussis toxin (PT
X)-sensitive G-proteins and since in-vitro studies have demonstrated enhanc
ed signal transduction of PTX-dependent pathways in the presence of the T-a
llele. Total peripheral resistance was determined as a parameter of vasocon
strictor tone and heart rate, stroke volume and systolic time intervals for
cardiac function. T-allele carriers had a significantly elevated stroke vo
lume and lower total peripheral resistance at baseline. After propranolol,
their fall in stroke volume was significantly greater. During alpha -methyi
noradrenaline infusion, elevation of total peripheral resistance was not in
creased relative to controls. Similarly, the constriction response of the d
orsal hand vein to azepexol was not different. Our study does not support t
he idea of increased vasoconstrictor tone in T-allele carriers either at re
st or during stimulation Of a(2)-adrenoceptors. However, this allele may be
associated with elevated cardiac stroke volume. Pharmacogenetics 11:461-47
0 (C) 2001 Lippincott Williams & Wilkins.